Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Dec 28 2021

Filgrastim / Sargramostim

  • Snapshot
    • A 55-year-old man with non-Hodgkin lymphoma undergoing chemotherapy is about to get his first dose of filgrastim, a granulocyte-colony stimulating factor, for his chemotherapy-induced neutropenia. A few minutes after the dose, he starts feeling pruritus, and it was noted by the nurse that he developed urticaria over his trunk. He did not experience swelling of his lips, tongue, or throat. He is given a dose of diphenhydramine and monitored for the next few hours. His urticaria subsides, and he continues to deny any difficulty breathing or throat swelling.
flashcard locked
Create a free account or log in to see the cards.
Private Note